Literature DB >> 23363007

Attrition from an Internet-based treatment program for female sexual dysfunction: who is best treated with this approach?

Marita P McCabe1, Lisa M Jones.   

Abstract

The current study evaluated the attrition from an Internet-based treatment program for female sexual dysfunction (FSD), and determined factors that contribute to this attrition. Of the original, 26 women who were allocated to the treatment group, 12 provided post-intervention data, and of the 27 women who entered the wait list control group, 22 provided post-intervention data. Of 14 control participants who then elected to enter treatment, five provided post-intervention data. Therefore, a total of 40 women entered the FSD program and 23 dropped out. Reasons for attrition included: relationship factors, lack of motivation, and time commitment perceived to be excessive. Significant differences were found in levels of relationship satisfaction and intimacy for those who dropped out and those who completed treatment. These findings suggest that participants with high relationship satisfaction and emotional intimacy with their partner are suitable for treatments of this type.

Entities:  

Mesh:

Year:  2013        PMID: 23363007     DOI: 10.1080/13548506.2013.764460

Source DB:  PubMed          Journal:  Psychol Health Med        ISSN: 1354-8506            Impact factor:   2.423


  3 in total

Review 1.  eHealth-Based Interventions for Older Patients with Prostate Cancer: A Quick Review of the Literature.

Authors:  Luiz Sinésio Silva Neto; Fellipe Camargo Ferreira Dias; Neila Barbosa Osório; Carmem Lucia Artioli Rolim
Journal:  Telemed Rep       Date:  2022-03-17

Review 2.  Internet-Based Interventions for Women's Sexual Dysfunction.

Authors:  Jacques van Lankveld
Journal:  Curr Sex Health Rep       Date:  2016-06-30

3.  Feasibility of a Brief Online Psychoeducational Intervention for Women With Sexual Interest/Arousal Disorder.

Authors:  Natasha Zippan; Kyle R Stephenson; Lori A Brotto
Journal:  J Sex Med       Date:  2020-09-09       Impact factor: 3.802

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.